Lipopolysaccharide reverses adrenocorticotrophic hormone-induced hypertension in the rat

Hypertension Research

Volumn 26, Issue 5, 2003, Pages 427-432

  Zhang, Yi ^b   Schyvens, Christopher G ^b   McKenzie, Katja U S ^b   Morris, Brian J ^a   Whitworth, Judith A ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Biology and Environment   (Australia)

Author keywords

Adrenocorticotrophic hormone; Hypertension; Lipopolysaccharide; Nitric oxide

Indexed keywords

CORTICOTROPIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SPIRONOLACTONE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; IATROGENIC DISEASE; MALE; METABOLISM; NONHUMAN; RAT; RAT STRAIN; SYSTOLIC BLOOD PRESSURE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; HYPERTENSION; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038173332     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.427     Document Type: Article

References (39)

1. Whitworth JA, Hewitson TD, Ming L, et al: Adrenocorticotrophin-induced hypertension in the rat: haemodynamic, metabolic and morphological characteristics. J Hypertens 1990; 8: 27-36.
2. Whitworth JA, Saines D, Thatcher R, Butkus A, Scoggins BA: Blood pressure and metabolic effects of ACTH in normotensive and hypertensive man. Clin Exp Hypertens A 1983; 5: 501-522.
3. + retention in man is not mediated by the mineralocorticoid receptor. J Clin Endocrinol Metab 1991; 72: 1060-1066.
4. Saruta T: Mechanism of glucocorticoid-induced hypertension. Hypertens Res 1996; 19: 1-8.
5. Li M, Wen C, Fraser T, Whitworth JA: Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism. J Hypertens 1999; 17: 419-426.
6. Clore JN, Estep H, Ross-Clunis H, Watlington CO: Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486. J Clin Endocrinol Metab 1988; 67: 824-831.
7. Whitworth JA, Gordon D, Andrews J, Scoggins BA: The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens 1989; 7: 537-549.
8. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA: L-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press 2000; 9: 298-304.
9. Turner SW, Wen C, Li M, Whitworth JA: L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996; 27: 184-189.
10. Wen C, Li M, Whitworth JA: Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine. Clin Exp Pharmacol Physiol 2000; 27: 887-890.
11. Altavilla D, Squadrito F, Serrano M, et al: Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats. Br J Pharmacol 1998; 124: 1293-1299.
12. Schwartz D, Mendonca M, Schwartz I, et al: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 1997; 100: 439-448.
13. Matsui E, Kitamura K, Yoshida M, et al: Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens Res 2001; 24: 543-549.
14. Ishimaru S, Shichiri M, Mineshita S, Hirata Y: Role of endothelin-1/endothelin receptor system in endotoxic shock rats. Hypertens Res 2001; 24: 119-126.
15. Fricker SP, Slade E, Powell NA, et al: Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Br J Pharmacol 1997; 122: 1441-1449.
16. Bloch J, Qiu C, Erdely A, Baylis C: Inhibition of inducible nitric oxide synthase during high dietary salt intake. Am J Hypertens 2002; 15: 230-235.
17. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-258.
18. Lang CH, Bagby GJ: Endotoxin tolerance diminishes endotoxin-induced alterations in carbohydrate kinetics. Circ Shock 1986; 20: 141-150.
19. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR: Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91: 271-275.
20. Hattori Y, Nakanishi N, Kasai K, Murakami Y, Shimoda S: Tetrahydrobiopterin and GTP cyclohydrolase I in a rat model of endotoxic shock: relation to nitric oxide synthesis. Exp Physiol 1996; 81: 665-671.
21. Bune AJ, Brand MP, Heales SJ, Shergill JK, Cammack R, Cook HT: Inhibition of tetrahydrobiopterin synthesis reduces in vivo nitric oxide production in experimental endotoxic shock. Biochem Biophys Res Commun 1996; 220: 13-19.
22. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ: Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-1233.
23. Torre-Amione G, Vooletich MT, Farmer JA: Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implications. Drugs 2000; 59: 745-751.
24. Schyvens CG, Zhang Y, McKenzie KU, Morris BJ, Whitworth JA: The effect of huTNFR:Fc on adrenocorticotrophic hormone (ACTH)-induced hypertension in the rat. 23rd Annual Scientific Meeting 2001, High Blood Pressure Research Council of Australia, No. 105 (Abstract).
25. Consentino F, Lüscher TF: Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res 1999; 43: 274-278.
26. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ: The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002; 20: 1035-1043.
27. Hafezi-Moghadam A, Simoncini T, Yang E, et al: Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-479.
28. Turner SW, Mangos GJ, Whitworth JA: Nitric oxide synthase activity in adrenocorticotrophin-induced hypertension in the rat. Clin Exp Pharmacol Physiol 2001; 28: 881-883.
29. Mangos GJ, Turner SW, Fraser TB, Whitworth JA: The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. J Hypertens 2000; 18: 1849-1855.
30. Li M, Dusting GJ, Whitworth JA: Inhibition of NO synthesis has an additive effect on hypertension induced by ACTH in conscious rats. Clin Exp Pharmacol Physiol 1992; 19: 675-681.
31. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA: Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem 1996; 271: 23928-23937.
32. Johns DG, Dorrance AM, Tramontini NL, Webb RC: Glucocorticoids inhibit tetrahydrobiopterin-dependent endothelial function. Exp Biol Med 2001; 226: 27-31
33. Li M, Fraser T, Wang J, Whitworth JA: Dexamethasone-induced hypertension in the rat: effects of L-arginine. Clin Exp Pharmacol Physiol 1997; 24: 730-732.
34. Radomski MW, Palmer RM, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047.
35. Lou YK, Wen C, Li M, et al: Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension 2001; 37: 1164-1170.
36. Andrews MC, Schyvens CG, McKenzie KU, Zhang Y, Whitworth JA: Adrenocorticotrophic hormone-induced hypertension in rats: reversal by nitric oxide donation. J Hypertens 2002; 20 (Suppl 4): S121 (Abstract).
37. Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA: Nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 1998; 25: 945-946.
38. Kelly JJ, Williamson P, Martin A, Whitworth JA: Effects of oral L-arginine on plasma nitrate and blood pressure in cortisol-treated humans. J Hypertens 2001; 19: 263-268.
39. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA: Cortisol inhibits cholinergic vasodilatation in the human forearm. Am J Hypertens 2000; 13: 1155-1160.